Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)

Candoni Anna; Rambaldi Alessandro; Fanin Renato; Velardi Andrea; Arcese William; Ciceri Fabio; lazzarotto Davide; Lussana Federico; Olivieri Jacopo; Grillo Giovanni; Parma Matteo; Bruno Benedetto; Sora Federica; Bernasconi Paolo; Saccardi Riccardo; Foa Robin; Sessa Mariarosa; Bresciani Paola; Giglio Fabio; Picardi Alessandra; Busca Alessandro; Sica Simona; Perruccio Katia; Zucchetti Elisa; Diral Elisa; Iori Anna Paola; Colombo Anna Amelia; Tringali Stefano; Santarone Stella; Irrera Giuseppe; Mancini Stefano; Zallio Francesco; Malagola Michele; Albano Francesco; Carella Angelo Michele; Olivieri Attilio; Tecchio Cristina; Dominietto Alida; Vacca Adriana; Sorasio Roberto; Orciuolo Enrico; Risitano Antonio Maria; Leotta Salvatore; Cortelezzi Agostino; Mammoliti Sonia; Oldani Elena; Bonifazi Francesca

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)

【24h】

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)

机译：None

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

We performed a nationwide registry-based analysis to describe the clinical outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who underwent an allogeneic hematopoietic stem cell transplantation (HSCT) after a tyrosine kinase inhibitor (TKI)-based treatment

机译：我们在全国范围内进行了基于注册管理机构的分析，以描述在酪氨酸激酶抑制剂（TKI）的治疗后经历同种异体造血干细胞移植（HSCT）的费城染色体阳性急性淋巴细胞白血病（pH +全部）的临床结果

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2019年第12期|共10页
作者
Candoni Anna; Rambaldi Alessandro; Fanin Renato; Velardi Andrea; Arcese William; Ciceri Fabio; lazzarotto Davide; Lussana Federico; Olivieri Jacopo; Grillo Giovanni; Parma Matteo; Bruno Benedetto; Sora Federica; Bernasconi Paolo; Saccardi Riccardo; Foa Robin; Sessa Mariarosa; Bresciani Paola; Giglio Fabio; Picardi Alessandra; Busca Alessandro; Sica Simona; Perruccio Katia; Zucchetti Elisa; Diral Elisa; Iori Anna Paola; Colombo Anna Amelia; Tringali Stefano; Santarone Stella; Irrera Giuseppe; Mancini Stefano; Zallio Francesco; Malagola Michele; Albano Francesco; Carella Angelo Michele; Olivieri Attilio; Tecchio Cristina; Dominietto Alida; Vacca Adriana; Sorasio Roberto; Orciuolo Enrico; Risitano Antonio Maria; Leotta Salvatore; Cortelezzi Agostino; Mammoliti Sonia; Oldani Elena; Bonifazi Francesca;
展开▼
作者单位

Univ Udine Hematol &

SCT Unit Azienda Sanit Univ Integrata Santa Maria Miserico Ple SM;

Univ Milan Dept Oncol Hematol Bergamo Italy;

Univ Udine Hematol &

SCT Unit Azienda Sanit Univ Integrata Santa Maria Miserico Ple SM;

Univ Perugia Hematol &

Clin Immunol Perugia Italy;

Univ Tor Vergata Rome Transplant Network Rome Italy;

Univ Vita Salute San Raffaele San Raffaele Sci Inst Hematol &

BMT Unit Milan Italy;

Univ Udine Hematol &

SCT Unit Azienda Sanit Univ Integrata Santa Maria Miserico Ple SM;

Azienda Socio Sanit Terr Papa Giovanni XXIII Dept Oncol Hematol Bergamo Italy;

Univ Udine Hematol &

SCT Unit Azienda Sanit Univ Integrata Santa Maria Miserico Ple SM;

Osped Niguarda Ca Granda Dept Hematol Oncol Milan Italy;

Osped San Gerardo Clin Ematol Monza Italy;

Univ Torino Dipartimento Biotecnol Mol &

Sci Salute Turin Italy;

Fdn Policlin Univ A Gemelli Ist Ematol Rome Italy;

Fdn IRCCS Policlin San Matteo Ctr Trapianti SC Ematol Pavia Italy;

Careggi Univ Hosp Ctr Trapianti Midollo Osseo Florence Italy;

Sapienza Univ Policlin Umberto 1 Dept Translat &

Precis Med Hematol Rome Italy;

Univ Hosp S Orsola Malpighi Inst Hematol L &

A Seragnoli Bologna Italy;

Univ Vita Salute San Raffaele San Raffaele Sci Inst Hematol &

BMT Unit Milan Italy;

Univ Tor Vergata Rome Transplant Network Rome Italy;

Fdn Policlin Univ A Gemelli Ist Ematol Rome Italy;

Univ Perugia Hematol &

Clin Immunol Perugia Italy;

Osped Niguarda Ca Granda Dept Hematol Oncol Milan Italy;

Sapienza Univ Policlin Umberto 1 Dept Translat &

Precis Med Hematol Rome Italy;

Fdn IRCCS Policlin San Matteo Ctr Trapianti SC Ematol Pavia Italy;

AOR Villa Sofia Cervello UOS Trapianto Midollo Palermo Italy;

Osped Civile Dipartimento Ematol Med Trasfus &

Biotecn Pescara Italy;

Grande Osped Metropolitano Bianchi Melacrino More Ctr Unico Reg Trapianto Cellule Staminali &

Azienda Osped San Camillo Forlanini Ctr Trapianti Cellule Staminali Rome Italy;

Azienda Osped S Antonio &

Biagio Unita Trapianti Midollo Alessandria Italy;

Univ Brescia ASST Spedali Civili Unit Blood Dis &

Stem Cell Transplantat Brescia Italy;

Univ Bari Dipartimento Emergenza &

Trapianti Organi Bari Italy;

Fdn IRCCS Casa Sollievo Sofferenza UO Ematol San Giovanni Rotondo Italy;

Univ Marche Osped Riuniti Hematol &

Bone Marrow Transplantat Ancona Italy;

Univ Verona Hematol Bone Marrow Transplant Unit Verona Italy;

IRCCS Osped Policlin San Martino UO Ematol Genoa Italy;

IRCCS Osped Policlin San Martino Ctr Trapianti Genoa Italy;

PO Roberto Binaghi UO Ematol CTMO Cagliari Italy;

Azienda Osped S Croce &

Carle SC Ematol Cuneo Italy;

Azienda Osped Univ Pisana UO Ematol Pisa Italy;

Univ Napoli Dept Clin Med &

Surg BMT Unit Naples Italy;

Azienda Policlin Vittorio Emanuele Programma Trapian Emopoiet Catania Italy;

Univ Milan Milan Italy;

Azienda Socio Sanit Terr Papa Giovanni XXIII Dept Oncol Hematol Bergamo Italy;

Univ Hosp S Orsola Malpighi Inst Hematol L &

A Seragnoli Bologna Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
Philadelphia chromosome-positive acute lymphoblastic leukemia; Allogeneic hematopoietic stem cell transplantation; Tyrosine kinase inhibitor;

机译：费城染色体阳性急性淋巴细胞白血病;同种异体造血干细胞移植;酪氨酸激酶抑制剂;

相似文献

外文文献
专利

1. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) [J] . Candoni Anna, Rambaldi Alessandro, Fanin Renato, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2019,第12期

机译：None
2. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with philadelphia chromosome-positive acute lymphoblastic leukemia: Impact of tyrosine kinase inhibitors on treatment outcomes [J] . KebriaeiP., SalibaR., RondonG., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2012,第4期

机译：费城染色体阳性的急性淋巴细胞白血病的同种异体造血干细胞移植的长期随访：酪氨酸激酶抑制剂对治疗结果的影响
3. The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience [J] . Doki Noriko, Igarashi Aiko, Najima Yuho, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：酪氨酸激酶抑制剂（TKI）时代的费城老年人染色体阳性（Ph +）急性淋巴细胞白血病（ALL）的同种异体造血干细胞移植（allo-HSCT）的临床结果：
4. Long-term outcome after bone marrow cell transplantation in patients with acute myocardial infarction [C] . I Zeus, M. Brehm, M. Kostering, Nordrhein-Westfa?lische Akademie der Wissenschaften . 2005

机译：骨髓细胞移植后急性心肌梗死患者的长期结果
5. Evidence for heterogeneous genetic associations with acute lymphoblastic leukemia (ALL) by cytogenetics, age, and sex in high-risk patients treated with matched unrelated donor allogeneic blood or marrow transplant (URD-BMT) [D] . Clay, Alyssa I. 2016

机译：通过匹配的无关供体同种异体造血或骨髓移植（URD-BMT）治疗的高危患者中，通过细胞遗传学，年龄和性别进行的与急性淋巴细胞白血病（ALL）异质遗传关联的证据
6. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research [O] . Aleksandr Lazaryan, Michelle Dolan, Mei-Jie Zhang, 2021

机译：同种异体造血干细胞移植后成人费城阴性急性淋巴细胞白血病的细胞遗传学异常的影响：国际血和骨髓移植研究中心急性白血病工作委员会的研究
7. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) [O] . Anna Candoni, Alessandro Rambaldi, Renato Fanin, 2019

机译：酪氨酸激酶抑制剂时代成年患者成年患者成年患者同种异体造血干细胞移植的结果：意大利血液移植协会的注册表研究（Gitmo）

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)

摘要

著录项

相似文献

相关主题

期刊订阅